Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederthelancet.com
Get the latest updates from The Lancet directly as they happen.
Follow now 102 followers
Last updated 1 day ago
1 day ago
Lutetium-177 (177Lu)-PSMA-617 is a radioligand therapy that targets prostate-specific membrane antigen (PSMA)...
1 day ago
Combining 177Lu-PSMA-617 with ADT plus ARPI prolonged radiographic progression-free survival in patients...
7 days ago
For selected patients with multivessel coronary artery disease, MICS CABG performed by...
7 days ago
The health-care system in the occupied Palestinian territory is undergoing a silent...
8 days ago
In people with type 2 diabetes, once-daily oral zenagamtide showed clinically meaningful...
8 days ago
In people with type 2 diabetes, once-weekly subcutaneous zenagamtide 0·4–40 mg demonstrated...
8 days ago
Since July 5, 2026, exceptionally heavy monsoon rainfall, runoff from surrounding hills...
8 days ago
The therapeutic landscape of type 2 diabetes and obesity has evolved from...
9 days ago
Psoriasis is a common, chronic, immune-mediated skin disease affecting more than 40...
9 days ago
Deramiocel safely slows disease progression in advanced DMD, preserving skeletal muscle function...
10 days ago
In patients with PAH receiving contemporary background therapy, ralinepag significantly reduced the...
12 days ago
We write to urge immediate access to medical care for Dr Hussam...